Literature DB >> 30970272

Current understanding of fear learning and memory in humans and animal models and the value of a linguistic approach for analyzing fear learning and memory in humans.

Jacob Raber1, Shahar Arzy2, Julie Boulanger Bertolus3, Brendan Depue4, Haley E Haas5, Stefan G Hofmann6, Maria Kangas7, Elizabeth Kensinger8, Christopher A Lowry9, Hilary A Marusak10, Jessica Minnier11, Anne-Marie Mouly3, Andreas Mühlberger12, Seth Davin Norrholm5, Kirsi Peltonen13, Graziano Pinna14, Christine Rabinak10, Youssef Shiban12, Hermona Soreq15, Michael A van der Kooij16, Leroy Lowe17, Leah T Weingast5, Paula Yamashita11, Sydney Weber Boutros18.   

Abstract

Fear is an emotion that serves as a driving factor in how organisms move through the world. In this review, we discuss the current understandings of the subjective experience of fear and the related biological processes involved in fear learning and memory. We first provide an overview of fear learning and memory in humans and animal models, encompassing the neurocircuitry and molecular mechanisms, the influence of genetic and environmental factors, and how fear learning paradigms have contributed to treatments for fear-related disorders, such as posttraumatic stress disorder. Current treatments as well as novel strategies, such as targeting the perisynaptic environment and use of virtual reality, are addressed. We review research on the subjective experience of fear and the role of autobiographical memory in fear-related disorders. We also discuss the gaps in our understanding of fear learning and memory, and the degree of consensus in the field. Lastly, the development of linguistic tools for assessments and treatment of fear learning and memory disorders is discussed.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Autobiography; Fear; Linguistics; Neuroanatomy; Neuropharmacology; Subjective fear; Virtual reality

Mesh:

Year:  2019        PMID: 30970272     DOI: 10.1016/j.neubiorev.2019.03.015

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  8 in total

Review 1.  The neuroscience of social feelings: mechanisms of adaptive social functioning.

Authors:  Paul J Eslinger; Silke Anders; Tommaso Ballarini; Sydney Boutros; Sören Krach; Annalina V Mayer; Jorge Moll; Tamara L Newton; Matthias L Schroeter; Ricardo de Oliveira-Souza; Jacob Raber; Gavin B Sullivan; James E Swain; Leroy Lowe; Roland Zahn
Journal:  Neurosci Biobehav Rev       Date:  2021-06-02       Impact factor: 9.052

2.  Allopregnanolone, the Neuromodulator Turned Therapeutic Agent: Thank You, Next?

Authors:  Graziano Pinna
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-14       Impact factor: 5.555

Review 3.  Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?

Authors:  Michele Tufano; Graziano Pinna
Journal:  Molecules       Date:  2020-02-27       Impact factor: 4.411

Review 4.  Allopregnanolone in Postpartum Depression.

Authors:  Graziano Pinna; Felipe B Almeida; John M Davis
Journal:  Front Glob Womens Health       Date:  2022-04-26

5.  Knowledge, attitudes, and practices [KAP] toward COVID-19: A cross-sectional study in the New York Metropolitan Area and California Bay Area.

Authors:  Erica Mark; Galina Udod; Jayne Skinner; Marieke Jones
Journal:  PLoS One       Date:  2022-08-10       Impact factor: 3.752

6.  Behavioral Phenotypes of Foxg1 Heterozygous Mice.

Authors:  Skyler Younger; Sydney Boutros; Francesca Cargnin; Shin Jeon; Jae W Lee; Soo-Kyung Lee; Jacob Raber
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

7.  Patterns of Cannabis Use Among Individuals with Obsessive-Compulsive Disorder: Results from an Internet Survey.

Authors:  Reilly R Kayser; Meredith S Senter; Rebecca Tobet; Marissa Raskin; Sapana Patel; H Blair Simpson
Journal:  J Obsessive Compuls Relat Disord       Date:  2021-07-13       Impact factor: 2.236

8.  Composite contributions of cerebrospinal fluid GABAergic neurosteroids, neuropeptide Y and interleukin-6 to PTSD symptom severity in men with PTSD.

Authors:  Byung Kil Kim; Jennifer R Fonda; Richard L Hauger; Graziano Pinna; George M Anderson; Ivan T Valovski; Ann M Rasmusson
Journal:  Neurobiol Stress       Date:  2020-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.